Infusion pump is a device used to deliver liquids into a patient’s body in a regulated manner, the pump enables to deliver fluid in large and small amounts. The pump is used to deliver both nutrients and medication in the patient’s body. Infusion pumps are regularly used to administer critical fluids, including high-risk medications, pump failures can have significant implications for patient safety.
The market for infusion pumps is expected to grow significantly due to factors such as, increasing incidence of chronic diseases, increasing number of surgical procedures performed and growing geriatric population. In addition, rising medical tourism in developing countries is anticipated to have a positive impact on the growth of the infusion pumps market in the coming years.
Download Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPHE100001112/
The market players are focused towards introducing new and innovative products in the market to sustain their position in the market. For instance, in December, 2018, Terumo Corporation announced that a biosimilar was launched in Europe. The biosimilar is used by company’s PLAJEX pre-fillable syringe. The hulio (biosimilar) is manufactured by the company. These product innovations and launches are expected to propel the growth of the infusion pumps market during the forecast period.
Some of the prominent players operating in infusion pumps market are BD, B. Braun Melsungen AG, Terumo Corporation, F. Hoffmann-La Roche Ltd., Medtronic, Baxter International, Inc., Smith Medical, Moog, Inc., ICU Medical, Inc., and Insulet Corporation
The report segments the global infusion pumps market as follows:
Global Infusion Pumps Market – By Type
Patient-Controlled Analgesia (PCA) Pumps
Global Infusion Pumps Market – By Application
Global Infusion Pumps Market – By End User
Hospitals & Clinics
Ambulatory Surgical Centers
Purchase this Report @ https://www.theinsightpartners.com/buy/TIPHE100001112/